Ataraxis, a New York-based startup specializing in AI-driven cancer diagnostics, has raised $20 million in venture capital to enhance its machine-learning tools for disease detection, particularly breast cancer. Founded by Dr. Jan Witowski and Dr. Krzysztof Geras, the company aims to leverage extensive patient data. Meanwhile, NYU Langone Health and the University of Glasgow have developed an AI tool for diagnosing lung cancer, showing 72% accuracy in predicting cancer recurrence, with plans to expand to other cancers.
